Assays for hepatitis B surface antigen (HBsAg) are the most frequently ... testing and also to ascertain likely cause of weakly positive (grayzone) results. Results During the 17 month study ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

We similarly followed 16 children of hepatitis B surface antigen (HBsAg)-positive mothers. Results: Of low risk infants receiving a plasma-derived vaccine, 41% (42 of 102) of those whose primary ...

Precision BioSciences (NASDAQ:DTIL) added ~6% in the premarket on Wednesday after the gene therapy developer announced ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus ... system in people who are either positive for the HBV surface antigen (HBsAg) or HBV core antibody ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

Hepatitis B surface antigen vaccine (recombinant ... of hepatitis B virus to infants born to mothers who are HBsAg positive if vaccination is delayed. Infants Weighing Less Than 2000 g Delay ...

A functional cure is said to have been achieved if a biomarker called hepatitis B surface antigen (HBsAg) is cleared from the blood and remains undetectable after stopping all treatment.

bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to 10% of participants ...

For patients at high risk of hepatitis B reactivation ... antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr.